Scientists warn climate change could cut crop yields up to a quarter, North America would be hit hardest
Climate change could cut crop yields up to a quarter. This file image was taken in Mitchel, Man. (Source: Don Moore)
Climate change is on track to reduce by 11 percent in 2100 the yields that today provide two-thirds of humanity's calories from crops, even taking into account adaptation to a warming world, scientists said Wednesday.
As soon as 2050, this 'moderate' scenario in which greenhouse gas emissions peak around 2040 and slowly taper off -- a trajectory aligned with current trends -- would see global losses of nearly eight percent.
And if carbon pollution worsens, the loss of calories across the same six staples -- corn, wheat, rice, soybeans, sorghum and cassava -- rises to nearly a quarter by century's end, the researchers reported in Nature.
More generally, every additional degree Celsius of warming reduces the world's ability to produce food from these crops by 120 calories per person per day, or nearly five percent of current daily consumption, they calculated.
'If the climate warms by three degrees, that's basically like everyone on the planet giving up breakfast,' said co-author Solomon Hsiang, a professor at the Stanford Doerr School of Sustainability in California.
The steepest losses will occur at the extremes of the agricultural economy: in modern, Big Ag breadbaskets that currently enjoy some of the world's best growing conditions, and in subsistence farming communities that typically rely of small cassava harvests.
North America would be hit hardest, losing a fifth of yields by 2100 in the moderate carbon pollution scenario, and two-fifths if emissions from burning fossil fuels continue apace.
Working with more than a dozen scientists, Hsiang and co-leader Andrew Hultgren, an assistant professor at the University of Urbana-Champaign, sifted through data from more than 12,000 regions in 55 countries.
Erratic weather
Previous calculations of how a warming world will impact crop yields generally failed to consider the ways in which farmers would adapt, such as switching crop varieties, shifting planting and harvesting dates, and altering fertiliser use.
The scientists estimated such adjustments would offset about a third of climate related losses over the next 75 years in the scenario of rising emissions, but that residual impacts would still be devastating.
'Any level of warming, even when accounting for adaptation, results in global output losses for agriculture,' said Hultgren.
With the planet about 1.5C hotter than preindustrial levels in the late 1900s, farmers in many regions are already experiencing longer dry spells, unseasonable heatwaves and erratic weather that undermines yields.
The nutritional value of most crops also declines with hotter temperatures, earlier research has shown.
The study revealed sharp variations in the impact of global warming on different crops and regions.
In the 'worst-case' scenario of rising carbon emissions, corn yields would plummet 40 percent by 2100 across the grain belt of the United States, eastern China, central Asia, and the Middle East.
For soybeans, yields in the US would decline by half, and increase by a fifth in Brazil.
Wheat losses would drop by a fifth in eastern and western Europe, and by 30 to 40 percent in other wheat-growing regions: China, Russia and North America.
Cassava would be hit hard everywhere it's grown.
'Although cassava does not make up a large portion of global agricultural revenues, it is an important subsistence crop in low- and middle-income countries,' the researchers pointed out.
Among the six crops examined, rice is the only one that stands to benefit in a warmer climate, mainly due to warmer nights.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
40 minutes ago
- Globe and Mail
Islet cell transplant trial outcome ‘major milestone' toward cure for diabetes
When Amanda Smith learned at the age of 25 that she had late-onset Type 1 diabetes, she considered the diagnosis a death sentence. The nurse, from London, Ont., had a particularly dim view of the disease because she grew up watching her mother struggle with it. Her mother would slur her words and lose consciousness when her blood sugar bottomed out. Once, Ms. Smith's grandfather had to break a window to reach her mother, who was passed out in her home holding a banana she had tried to consume to raise her blood sugar. 'It literally eats you from the inside out,' said Ms. Smith, now 36. 'It rots your teeth, it destroys your body, your vision. The complications that come with Type 1 diabetes are so extreme.' Ms. Smith is confident now that those complications won't be in her future. In February of 2023, she became the first Canadian to receive a transplant of islet cells – the cells in the pancreas that make insulin – derived from embryonic stem cells. The transplant freed her from insulin and gave her blood sugar control akin to a non-diabetic. It was performed at Toronto General Hospital, the institution where insulin was first tested more than 100 years ago. On Friday, the results of the clinical trial in which Ms. Smith participated were published in the New England Journal of Medicine. The early-phase trial was small, and the procedure has a significant downside in that patients must take anti-rejection drugs for life, just like recipients of organ transplants. For people living with diabetes, the push for medical coverage isn't political, it's personal Nonetheless, the study's outcome counts as 'spectacular,' according to James Shapiro, who holds the Canada Research Chair in transplant surgery and regenerative medicine at the University of Alberta and was not involved in the study. Ten of the 12 participants who received a full dose of the cells were insulin-independent one year later. 'This is a major advance and a major milestone along the journey towards a cure,' he said. Dr. Shapiro was himself responsible for an earlier breakthrough on that path. In 2000, he and his colleagues at the University of Alberta published a seminal paper on a method they developed for safely and effectively transplanting islet cells from deceased donors into patients with Type 1 diabetes. They dubbed their regimen the 'Edmonton Protocol.' 'We used to call it the drive-through transplant,' Dr. Shapiro said, because giving patients islet cells was less risky and burdensome than a whole pancreas transplant. The cells are infused into patients under mild sedation with an IV-drip into the portal vein of the liver. The breakthrough described in the new paper is that the islet cells transplanted into Ms. Smith were derived not from deceased donors but from embryonic stem cells, which function as a type of source code that scientists can coax into becoming any cell in the human body. The supply of such lab-created islets could, in theory, be limitless, unlike the supply of deceased donor islets. Semaglutide, or Ozempic, reduces symptoms of feared diabetes' complication, study finds Trevor Reichman, director of the pancreas and islet transplant program at the University Health Network's Ajmera Transplant Centre, said the most encouraging result is that the islet-cell transplants eliminated dangerous blood sugar 'lows' that can cause confusion, seizures and unconsciousness. He ran the study site at UHN and is an author of the new paper. 'All of them, essentially, were able to get rid of their hypoglycemic episodes,' Dr. Reichman said, 'so all of the real risks to them, all of the lows, were essentially eliminated.' Still, the international trial, funded by Boston-based Vertex Pharmaceuticals, wasn't without its challenges. The company paused it temporarily last year after two participants died, though not from taking Zimislecel, the brand name of the new islet therapy. Vertex expects to apply for regulatory approval of Zimislecel starting next year. One participant died of severe dementia 30 months after the infusion. That patient had pre-existing neurocognitive impairment and, before joining the trial, had suffered a brain injury during a motor-vehicle accident caused by a severe blood sugar low. The other died of cryptococcal meningitis, a fungal infection caused by a sinus surgery. The death was related to the immunosuppressant medication that the participant was taking to preserve the islet transplant, the study said. That death underscores the tradeoff that people with Type 1 diabetes would have to make with Zimislecel, said Rémi Rabasa-Lhoret, director of the Metabolic Diseases Research Unit and The Diabetes Clinic at the Montreal Clinical Research Institute. He wonders how many people with Type 1 would be willing to take anti-rejection drugs for life, especially now that advances such as insulin pumps have made diabetes easier to manage for some patients. 'It's probably going to be a very narrow population,' Dr. Rabasa-Lhoret said. The next step for scientists is finding a way to genetically engineer or encapsulate islets so the immune system won't view them as hostile invaders. In the meantime, Ms. Smith said taking three pills, three times a day to suppress her immune system is a breeze compared with the round-the-clock work of keeping her blood sugar in check. Her 10-year-old daughter, Draya, used to say she wanted to become a doctor to cure diabetes. Now, she talks of being a pilot or engineer. 'I would do this a million times over compared to the maintenance I used to have to do to keep myself alive,' Ms. Smith said.
CTV News
2 hours ago
- CTV News
Montreal teen tops global chemistry competition
Rama Jamal Alhashemi placed first in the world at the international Avogadro Chemistry Competition. Solutions and gases are no match for 17-year-old Rama Jamal Alhashemi, who placed first in the world in the international Avogadro Chemistry Competition. 'Today we're going to be doing a neutralization reaction with 0.1 molar of NaOH sodium hydroxide and one molar of hydrochloric acid, which is HCL.,' she explained. From the moment she set foot in the laboratory, the recent high school graduate was enamoured with periodic elements. She also took a liking to titration experiments - the process of determining the concentration of solutions. 'To know when our titration is over, we're going to put in some indicator phenolphthalein. So this indicator will make the solution turn pink,' Alhashemi said while demonstrating. Last month, her skills were put to the test in the international Avogadro Chemistry Competition. The exam consists of 40 multiple-choice questions on the structure of matter and chemical reactions. 'It's put on by the University of Waterloo and in the past 37 years, there's been about 174,000 students across the world who have written the competition,' said Sarah Howard, a senior school science teacher at The Study. Only '0.2 per cent of those people have achieved what Rama achieved,' Howard added. Alhashemi placed first in Quebec, first in Canada, first in North America and first in the world. Her ranking earned her a certificate of distinction and an elemental tile for outstanding achievement. 'It's an amazing shock,' Alhashemi said. It's a reminder that 'females can be strong in STEM topics and it's something that we should be encouraging more,' Howard told CTV. According to Statistics Canada, women make up less than 30 per cent of those employed in a STEM field. However, as the soon-to-be CEGEP student gears up for Honours Health Science studies at Marianopolis College, she also plans to explore other interests. 'I've been playing the alto saxophone [...] ever since grade six. So I want to continue not only the sciences in the future but keep music on the side as well.'
CBC
9 hours ago
- CBC
The northern cod quota increase is a scientific oversight or an economic win — depending on who you ask
Federal Fisheries Minister Joanne Thompson said the decision to double the total allowable catch to 38,000 metric tonnes was based on science. But one scientist disagrees. Meanwhile, other groups say it will bring jobs back. The CBC's Todd O'Brien reports.
